악성 난소 생식세포 종양 환자의 항암 치료 후 발생한 부작용 증상에 대한 한방치료 증례 보고 1례

키워드

참고문헌 (43)

1. The Society of Korean Medicine Obstetrics and Gynecology, "Oriental Obstetrics & Gynecology", pp.347~352 (2012), Publishing Co. Eui Seong Dang
2. Cancer registration ⋅Statistics Program, "Ministry of Health and Welfare", ~ (2016)
3. Jacobs IJ, "Screening for ovarian cancer : a pilot randomized controlled trial", Lancet, 353(9160), pp.1207~1210 (1999)
4. Nogales FF, "Germ cell tumors of the ovary : an update", Arch Pathol Lab Med, 138(3), pp.351~362 (2014)
5. Nawa A, "Prognostic factors of patients with yolk sac tumors of the ovary", Am J Obstet Gynecol, 184(6), pp.1182~1188 (2001)
6. Williams SD, "Adjuvant therapy of ovarian germ cell tumors with cisplaitn, etoposide, and bleomycin : a trial of the Gynecologic Oncology Group", Gynecol Oncol, 95(3), pp.496~499 (2004)
7. David M, "Managemnt of Early Ovarian Cancer : Germ cell and Sex Cord-Stromal Tumors", Gynecol Oncol, 55(3), pp.562~572 (1994)
8. Zanetta G, "Survival and reproductive function after treatment of malignant germ cell ovarian tumors", J Clin Oncol, 19(4), pp.1015~1020 (2001)
9. 이강욱, "유방암 치료에 대한 한의 임상 가이드라인 개발을 위한 기초연구", 대한한방부인과학회지, 29(2), pp.47~65 (2016), 대한한방부인과학회[DOI]
10. Mead GM, "The International Germ Cell Consensus Classification : a new prognostic factor-based staging classification for metastatic germ cell tumors", Clin Oncol, 9(4), pp.207~209 (1997)
11. Kim CM, "The encyclopedia of oriental herbal medicine", pp.3473~3479 (1997), Publishing Co. Jungdam
12. Wang JH, "20(s)-ginsenoside Rg3 promotes apoptosis in human ovarian cancer HO-8910 cells through PI3K", Akt and XIAP pathways, 2014, pp.35(12), 11985~11994
13. Xu TM, "Inhibitory effect of ginsenoside Rg3 on ovarian cancer metastasis", Chin Med J(Engl), 121(15), pp.1394~1397 (2008)
14. Ting Liu, "Ginsenoside 20(S)-Rg3 Targets HIF-1α to Block Hypoxia-Induced Epithelial-Mesenchymal Transition in Ovarian Cancer Cells", PLoS ONE, 9(9), pp.e103887~ (2014)
15. Li J, "Ginsenoside 20(S)-Rg3 inhibits the Warburg effect through STAT3 pathways in ovarian cancer cells", Int J Oncol, 46(2), pp.775~781 (2015)
16. Zheng X, "Ginsenoside 20(S)-Rg3 induced autophagy to inhibit migration and invasion of ovarian cancer", Biomed Pharmacother, 85, pp.620~626 (2017)
17. National Compilation Committee of Korean Medicine college(全國 韓醫科大學 共同敎材編纂委員會), "Herbalogy (本草學)", pp.320~324 (2016), Publishing Co. Young rim
18. 강희, "黃기에 의한 Helper T 세포의 생존 및 활성 증가", 동의생리병리학회지, 15(4), pp.560~565 (2001), 한의병리학회
19. Cho WC, "In vitro and in vivo anti-tumor effects of Astragalus membranaceus", Cancer Lett, 252(1), pp.43~54 (2007)
20. Evan GI, "Proliferation, cell cycle and apoptosis in cancer", Nature, 411(6835), pp.342~348 (2011)
21. 박준규, "黃芪가 in vitro에서 子宮筋腫細胞에 미치는 影響", 대한한방부인과학회지, 21(2), pp.49~58 (2008), 대한한방부인과학회
22. Lee DH, "A case report of metastatic breast cancer treated with korean medicine therapy as a substitute for chemotherapy", Case Rep Oncol, 10(1), pp.27~36 (2017)
23. 한가진, "진행성 유방암에 대한 한양방 병용 치료 치험 1례", 대한한방내과학회지, 39(2), pp.268~276 (2018), 대한한방내과학회
24. Shin MG, "Clinical Traditional Herbalogy", pp.55~57 (1989), Publishing Co. Young-rim
25. 송미선, "乾漆에 對한 文獻的 考察", 대한한방부인과학회지, 15(1), pp.61~76 (2002), 대한한방부인과학회
26. David D. Kitts, "Antitumorigenic and cytotoxic properties of an ethanol extract dervied from Rhus Verniciflua Stokes", J Toxical Environ Health A, 64(4), pp.357~371 (2001)
27. Oh PS, "Glycoprotein Isolated from Rhus verniciflua stokes Inhibits Inflammation-Related Protein and Nitric Oxide Production in LPS-Stimulated RAW 264.7 Cells", Biol Pharm Bull, 30(1), pp.111~116 (2007)
28. Nancy A, "The caspase family of cysteine proteases", British Medical Bulletin, 53(3), pp.478~490 (1997)
29. Lee JH, "The effect of G2 cell cycle arrest in ATM", ATR-cdc25c-cdc2-cyclin B pathway by Butein-the active material of Rhus verniciflua stokes in Human breast cancer MCF-7 cell lines, Kyung Hee Graduate School, pp.Department of Oriental Medicine, 2010
30. Jang HJ, "Molecular mechanism by which Resina Toxicodendrii induces apoptosis and suppresses chemo-resistance in MCF-7", DOX cells, Kyung Hee Graduate School, pp.Department of Clinical Korean Medicine, 2017
31. Williams P, "Apoptosis: Pharmacological Implications and Therapeutic Opportunities", Mayo Clinic Proceedings, 73(9), pp.917~ (1998)
32. 한가진, "유방암에 대한 한양방 병용 치료 증례 보고 1례", 대한한방내과학회지, 38(5), pp.820~827 (2017), 대한한방내과학회
33. Kwon SJ, "EuiMunChuiEeon(醫門贅言)", pp.124~126 (2014), Publishing Co. Eui bang
34. Lee JD, "The Physio-pathology of Oriental Medicine with 30 Essential Herbal Formulas", pp.414~440 (2015), Publishing Co. Jeong-dam
35. Kwon SW, "Korean Internal Medicine Diagnosis&Treatment (韓方內科 診察診斷 治療)", pp.84~88 (2017), Guide. Gaonhamedia
36. Dundee JW, "Acupuncture prophylaxis of cancer chemotherapy-induced sickness", J R Soc Med, 82(5), pp.268~271 (1989)
37. Ohno T, "Rikkunshito, a traditional Japanese medicine, suppresses cisplatin-induced anorexia in humans", Clin Exp Gastroenterol, 4(1), pp.291~296 (2011)
38. Lin JC, "Phase III Study of Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Nasopharyngeal Carcinoma : Positive Effect on Overall and Progression-Free Survival", J Clin Oncol, 21(4), pp.631~637 (2003)
39. Huddart RA, "A randomised phase 2 trial of intensive induction chemotherapy(CBOP", BEP)and standard BEP in poor-prognosis germ cell tumours(MRC TE23, CRUK 05, Eur Urol, pp.2015, 67(3)[DOI]
40. Tryakin A, "Paclitaxel+BEP(T-BEP)regimen as induction chemotherapy in poor prognosis patients with non-seminomatous germ cell tumors : a phase II study", Urology, 78(3), pp.620~625 (2011)
41. Kier MG, "Prognostic Factors and Treatment Results After Bleomycin, Etoposide, and Cisplatin in Germ Cell Cancer : A Population-based Study", Eur Urol, 71(2), pp.290~298 (2017)
42. Chang HJ, "A case of Ovarian Mixed Germ cell tumor with rapid relapse", Journal of Gynecologic Oncology, 13(2), pp.171~ (2002)
43. 김창석, "한양방 병용치료에 대한 문헌고찰", 한국한의학연구원논문집, 18(2), pp.101~116 (2012), 한국한의학연구원

관련 논문AI추천